Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Phase I/II Study of Intra-Arterial Melphalan Given With Intra-Arterial Carboplatin, Osmotic Blood-Brain Barrier Disruption and Delayed Otoprotective Sodium Thiosulfate for Patients With Recurrent or Progressive CNS Embryonal or Germ Cell Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00983398
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:26.230679+00:00
Published At
2021-10-26T00:00:00+00:00
Record Updated At
2021-10-26
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Central Nervous System Embryonal Neoplasm", "Embryonal Tumor With Multilayered Rosettes, C19MC-Altered", "Germ Cell Tumor", "Medulloblastoma", "Medulloepithelioma", "Primitive Neuroectodermal Tumor", "Recurrent Childhood Central Nervous System Embryonal Neoplasm", "Recurrent Malignant Germ Cell Tumor", "Recurrent Medulloblastoma", "Recurrent Primitive Neuroectodermal Tumor"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-10-26"
protocolSection.identificationModule.nctId
"NCT00983398"
protocolSection.identificationModule.officialTitle
"Phase I/II Study of Intra-Arterial Melphalan Given With Intra-Arterial Carboplatin, Osmotic Blood-Brain Barrier Disruption and Delayed Otoprotective Sodium Thiosulfate for Patients With Recurrent or Progressive CNS Embryonal or Germ Cell Tumors"
protocolSection.statusModule.overallStatus
"UNKNOWN"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Central Nervous System Embryonal Neoplasm (protocolSection.conditionsModule.conditions)
  • Embryonal Tumor With Multilayered Rosettes, C19MC-Altered (protocolSection.conditionsModule.conditions)
  • Germ Cell Tumor (protocolSection.conditionsModule.conditions)
  • Medulloblastoma (protocolSection.conditionsModule.conditions)
  • Medulloepithelioma (protocolSection.conditionsModule.conditions)
  • Primitive Neuroectodermal Tumor (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Central Nervous System Embryonal Neoplasm (protocolSection.conditionsModule.conditions)
  • Recurrent Malignant Germ Cell Tumor (protocolSection.conditionsModule.conditions)
  • Recurrent Medulloblastoma (protocolSection.conditionsModule.conditions)
  • Recurrent Primitive Neuroectodermal Tumor (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.